Weekly review: Neffy pre-ordering launches, trofinetide data, and more

Pre-ordering for epinephrine nasal spray (neffy) has launched for treating allergic reactions, including anaphylaxis. The FDA approved trofinetide (Daybue) for Rett syndrome, marking a milestone in treatment. A study in JAMA Pediatrics found not all screen time before bed negatively impacts sleep in children. Another study in The American Journal of Clinical Nutrition linked fish intake during pregnancy to reduced autism risk in children.